Edition:
United Kingdom

Sunesis Pharmaceuticals Inc (SNSS.OQ)

SNSS.OQ on NASDAQ Stock Exchange Capital Market

6.64USD
23 Feb 2018
Change (% chg)

$-0.15 (-2.21%)
Prev Close
$6.79
Open
$6.77
Day's High
$6.77
Day's Low
$6.34
Volume
52,840
Avg. Vol
39,865
52-wk High
$7.25
52-wk Low
$1.84

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 0.00 -0.411
Mar '17 0.67 -0.468
FY 2016 Dec '16 0.68 -0.442
Sep '16 0.61 -0.617
Jun '16 0.61 -0.721
Mar '16 0.64 -0.698
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 0.30 0.60 0.00 --
Quarter Ending Jun-18 2 0.30 0.60 0.00 --
Year Ending Dec-18 5 0.58 2.40 0.00 5.00
Earnings (per share)
Quarter Ending Mar-18 2 -0.20 -0.17 -0.24 --
Quarter Ending Jun-18 2 -0.25 -0.25 -0.25 --
Year Ending Dec-18 5 -0.95 -0.80 -1.16 -1.20
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.93 32.90
P/E High - Last 5 Yrs. -- 292.71 45.97
P/E Low - Last 5 Yrs. -- 91.44 24.37
Beta 1.38 0.90 0.89
Price to Sales (TTM) 28.99 110.72 5.77
Price to Book (MRQ) -- 13.56 5.41
Price to Tangible Book (MRQ) 4.54 14.02 6.98
Price to Cash Flow (TTM) -- 71.33 23.42
% Owned Institutions 68.49 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.66 5.21
Payout Ratio(TTM) -- 15.70 43.73

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 398.34 9.24
Sales (TTM) vs TTM 1 Yr. Ago -24.89 78.63 5.59
Sales - 5 Yr. Growth Rate -12.70 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 43.00 25.10 19.66
EPS (TTM) vs TTM 1 Yr. Ago 32.89 -- --
EPS - 5 Yr. Growth Rate -- 38.95 10.73
Capital Spending - 5 Yr. Growth Rate -- 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.18
Current Ratio (MRQ) 3.37 5.30 2.97
LT Debt to Equity (MRQ) 43.49 22.82 12.22
Total Debt to Equity (MRQ) 56.85 24.47 16.52
Interest Coverage (TTM) -32.04 -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.03 54.70
Gross Margin - 5 Yr. Avg. -- 51.06 52.42
EBITD Margin (TTM) -1,771.92 -- --
EBITD - 5 Yr. Avg -811.88 -572.68 10.86
Operating Margin (TTM) -1,772.38 -717.10 4.64
Operating Margin - 5 Yr. Avg. -812.40 -594.00 6.26
Pre-Tax Margin (TTM) -1,849.97 -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. -851.74 -597.35 6.60
Net Profit Margin (TTM) -1,849.97 -692.88 1.76
Net Profit Margin - 5 Yr. Avg. -851.74 -600.21 2.91
Effective Tax Rate (TTM) -- 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 52,838 22,602,130 855,673,508
Net Income/Employee (TTM) -977,486 2,968,748 100,656,226
Receivable Turnover (TTM) -- 20.14 5.78
Inventory Turnover (TTM) -- 2.36 3.35
Asset Turnover (TTM) 0.07 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -122.85 -1.05 10.98
Return on Assets - 5 Yr. Avg. -78.71 -0.57 12.37
Return on Investment (TTM) -174.35 1.66 14.43
Return on Investment - 5 Yr. Avg. -154.42 2.23 16.18
Return on Equity (TTM) -- 2.58 16.13
Return on Equity - 5 Yr. Avg. -430.12 3.13 17.47
  1 Year 3 Year 5 Year
Sales % -17.15 -31.69 -12.70
EPS (TTM) % 19.67 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Sunesis Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 75.37%
# of Holders: 53
Total Shares Held: 25,813,379
3 Mo. Net Change: 10,192,246
# New Positions: 14
# Closed Positions: 9
# Increased Positions: 28
# Reduced Positions: 16
# Net Buyers: 12
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.